Veterinary Medicines

TILDREN 5 MG/ML POWDER AND SOLVENT FOR SOLUTION FOR INJECTION FOR HORSES

Authorised
  • Tiludronate disodium hemihydrate
Download as PDF

Product identification

Medicine name:
TILDREN 5 MG/ML POWDER AND SOLVENT FOR SOLUTION FOR INJECTION FOR HORSES
TILDREN®
Active substance:
  • Tiludronate disodium hemihydrate
Target species:
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Tiludronate disodium hemihydrate
    5.83
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Powder and solvent for solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM05BA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Audevard
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 02-1588
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0134/001
Concerned member states:
  • Austria
  • Greece
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 10/10/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 10/10/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."